Adipotsitokiny: rezistin i faktor nekroza opukholey-α u muzhchin s abdominal'nym ozhireniem

1. Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. РМЖ. 2001;2(9):56-60.

2. Ожирение / под ред. Дедова И.И. и Мельниченко Г.А. — М., 2004.

3. Bo S., Gambino R., Pagani A., at al. Relationships between human serum resistin, inflammatory markers and insulin resistance. International Journal of Obesity. 2005;29:1315-1320.

4. Chandron M., Phillips S., Ciaraidi T. at al. Adiponectin: more then just another fat cell hormone? Diabetes Care. 2003;26:2442-2450.

5. Corica F., Allegra A., Corsonello A. et al. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects. Int J Obes Relat Metab Disord. 1999;23(4):355-360.

6. Dalziel B., Gosby A, Richman R. et al. Association of the TNF- -308 G/A Promoter Polymorphism with Insulin Resistance in Obesity. Obesity Research. 2002;10:401-407.

7. Demirbas B., Guler S., Cakir B. et al. Plasma tumor necrosis factor-alpha levels and insulin resistance in nondiabetic hypertensive subjects. Horm Res. 2002;58(6):283-286.

8. Farvid M., Ng T., Chan D. et al. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes, Obesity and Metabolism. 2005;7(4):406-413.

9. Fruhbeck G., Gomez-Ambrosi J. et al. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. AJP Endocrinology and Metabolism. 2001;280:Е827-Е847.

10. Gabriele E. Sonnenberg, Glenn R. Krakower and Ahmed H. Kissebah. A Novel Pathway to the Manifestations of Metabolic Syndrome. Obesity Research. 2004;12:180-186.

11. Hotamisligil G.S. Molecular mechanism of insulin resistance and the role of the adipocyte. International Journal of Obesity. 2000; 4 (Suppl. 4):23-27.

12. Janke J., Engeli S., Gorzelniak K. et al. Resistin gene expression in human adipocytes is not related to insulin resistance. Obesity Research. 2002;10:1-5.

13. Krystyna M. Kras, Dorothy B. Hausman and Roy J. Martin. Tumor Necrosis Factor-Stimulates Cell Proliferation in Adipose Tissue-Derived Stromal-Vascular Cell Culture: Promotion of Adipose Tissue Expansion by Paracrine Growth Factors. Obesity Research. 2000;8:186-193.

14. Lais U. Monzillo, Osama Hamdy, Edward S. Horton at al. Effect of Lifestyle Modification on Adipokine Levels in Obese Subjects with Insulin Resistance. Obesity Research. 2003;11:1048-1054.

15. Matthews D., Hosker J., Rudenski A. at al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.

16. Ohya M., Taniguchi A., Fukushima M. et al. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients. Metabolism. 2005;54(10):1297-1301.

17. Rajala M., Qi Y., Patel Н. et al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes. 2004;53(7):1671-1679.

18. Reilly M., Lehrke M., Wolfe M. et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111:932-939.

19. Shuldier A., Yang R., Gong D-W. Resistin, obesity and insulin resistance. N Engl J Med. 2001;345:1345-1346.

20. Smith U. Resistin - resistant to defining its role. Obesity Research. 2002;10:61-62.

21. Steppan C., Bailey S., Bhat S. et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307-312.

22. Ukkola O. Mini-review: Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander? European Journal of Endocrinology. 2002;147(5):571-574.

23. Zinman B., Hanley A.J., Harris S.B. et al. Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999; 4(1):272-278.